Table 1.
Clinical characteristics of the cohort of patients and type of symptoms at onset.
| Clinical characteristics | n [IQR] | % |
|---|---|---|
| Female, n | 15 | 96.8 |
| Age, years | 37 [31–43] | |
| Occupation | ||
| Health professional, n | 7(43.8%) | 43.8 |
| Other, n | 9 | 56.2 |
| BMI, kg/m2 (/15) | 22.1 [19.8–25.2] | |
| Allergy | 8 | 50 |
| Respiratory, n | 5 | 31.3 |
| Drug, n | 3 | 18.8 |
| Other, n | 2 | 12.5 |
| Autoimmune disease, n | 5 | 31.3 |
| Personal history | 3 | 18.8 |
| Familial history | 2 | 12.5 |
| Tobacco use, n | 1 (2 former smokers) | |
| Sport, n (/13) | 9/13 | 69.2 |
| At first SARS-CoV-2 episode | ||
| SARS-CoV-2 RT-PCR (/14) + | 6/14 | 42.9 |
| SARS COV 2 serology + | 7/16 | 43.8 |
| Symptoms (n patients) | Acute | |
| Asthenia | 14 | 87.5 |
| Headache | 9 | 56 |
| Anosmia/dysgeusia | 9 | 56 |
| Dyspnea | 10 | 62 |
| Chest pain and oppression | 6 | 37.5 |
| Cough | 13 | 81 |
| Fever/shivering | 11 | 69 |
| Myalgia/arthralgia | 4 | 25 |
| Odynophagia | 7 | 43.8 |
| Other neurological symptoms | 3 | 18.8 |
| Sensory symptoms | 0 | 0 |
| Ophthalmological symptoms | 2 | 12.5 |
| Other cardiopulmonary symptoms | 0 | 0 |
| Rhinorrhea | 8 | 50 |
| Cognitive symptoms | 1 | 6 |
| Palpitations/tachycardia | 5 ara> | 31 |
| Auditory symptoms | 0 | 0 |
| Skin/venous symptoms | 3 | 18.8 |
| Other | ||
| Nijmegen score elevated > 23/64 | 14/16 | 87.5 |
| SSD12 score elevated > 12 | 7/13 | 43.8 |
| Brain PET scan hypometabolism | 12/15 | 80.0 |
Data were available for all 16 patients unless otherwise indicated; n, number of patients; IQR, interquartile range.